Gojo, Javelle B.
HRN: 28-18-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/17/2025
CEFTAZIDIME 1GM (VIAL)
12/17/2025
12/24/2025
IV
140mg
Q8
Neonatal Sepsis
Checking Final Appropriateness
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes